Ma, L., Bian, X., & Lin, W. (2020). The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer. J Exp Clin Cancer Res.
Citação norma ChicagoMa, Liying, Xing Bian, and Wenchu Lin. "The Dual HDAC-PI3K Inhibitor CUDC-907 Displays Single-agent Activity and Synergizes With PARP Inhibitor Olaparib in Small Cell Lung Cancer." J Exp Clin Cancer Res 2020.
MLA CitationMa, Liying, Xing Bian, and Wenchu Lin. "The Dual HDAC-PI3K Inhibitor CUDC-907 Displays Single-agent Activity and Synergizes With PARP Inhibitor Olaparib in Small Cell Lung Cancer." J Exp Clin Cancer Res 2020.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.